创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

糖组检测在肝脏疾病诊疗中的应用现状与未来展望

Application Status and Future Prospect of Glycome Test in Liver Disease Diagnosis and Treatment

  • 摘要: 糖组泛指在特定的时间、空间和环境下细胞和组织产生的所有糖链的集合。蛋白上糖链的合成受到了基因的严格调控,且很少受环境影响。并且,个体水平上血清中糖组非常稳定。研究人员在肝病研究中发现,岩藻糖、多分支、平分N-乙酰葡糖胺和唾液酸等糖型均发生了显著的变化。综述了糖组检测在肝纤维化、肝硬化、肝癌的诊疗及肝移植中的应用进展。

     

    Abstract: Glycome refers to the collection of glycans produced by cell and tissue under defined situations of time, location and environment. Synthesis of glycan on protein is strictly regulated by genes while rarely affected by the environment. Besides, Serum glycome is very stable at the individual level. In the studies of liver diseases, researchers have found significant changes in fucosylation, brancing, bisecting N-acetylglucosamine and sialic acid of glycans. This article reviews the advances in the application of glycome test in the diagnosis and treatment of liver fibrosis, liver cirrhosis, liver cancer and liver transplantation.

     

/

返回文章
返回